CurveAssure Receives First Institutional Capital From 1891 Angels as it Seeks to Improve Outcomes in Spine Surgery and Beyond
February 27, 2025
CurveAssure, a leading spine movement and data capture company, has secured significant investments from 1891 Angels, a VC fund focused on the Johns Hopkins startup ecosystem. With its patented products for movement tracking and spinal assessment, CurveAssure has gained the trust and support of orthopedic industry leaders.
CurveAssure is an AI-powered patient assessment platform that transforms any standard smartphone into a powerful motion analysis tool, delivering real-time, objective data to optimize patient care. The technology spinout of Johns Hopkins is redefining how clinicians assess movement, making patient assessments faster, more precise, and more accessible. CurveAssure is poised to become the new standard for musculoskeletal care.
The company’s lead medical advisor and co-founder is Dr. Nicholas Theodore, a world-renowned spine surgeon who has had multiple prior successful exits. The CEO, Evan Haas, is an alumnus of Johns Hopkins, where he did a master’s and a fellowship in Bioengineering Innovation and Design. They are located and expanding operations in Baltimore, Maryland. With multiple pilots set to launch and a growing network of orthopedic and MedTech leaders backing its vision, CurveAssure is accelerating toward broad adoption—bringing a scalable, AI-driven solution to one of healthcare’s most pressing challenges.
1891 Angels is an exclusive independent angel investor group dedicated to empowering startups within the Johns Hopkins community. Members of the group consist of Hopkins alums, and investments are focused on companies with strong Johns Hopkins affiliations, whether through founders or key team members. 1891 Angels leveraged the diverse talents, expertise, and networks of the Hopkins alumni community to fuel the success and growth of innovative ventures.
“Supporting CurveAssure aligns perfectly with our mission at 1891 Angels, which is to foster innovation and collaboration in the Hopkins startup ecosystem,” says Jeff Spitz, 1891 Angels Partner. “Investing in and providing other 1891 Angels resources to CurveAssure is a natural fit. We believe in their technology and see potential in their testing to improve patient outcomes. We are excited about its potential to revolutionize patient care and elevate orthopedic care globally,” adds Kentucky Morrow, 1891 Angels Partner.
“We sincerely thank 1891 Angels for their unwavering partnership and support,” said Evan Haas, CurveAssure founder and CEO. “We are equally thrilled to have such a robust network of experts supporting our mission through 1891 Angels, whose investments further strengthen our position in the industry. Together, we will bring a future where dynamic patient assessments make spine and orthopedic care smarter, more efficient, and truly personalized.”